MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory—including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 ...

When these elements come together, a geriatric program transforms from an aspirational concept into a practical reality. The practice becomes not only a provider of medical services but also a trusted ...

Halozyme Therapeutics, Inc. today announced the Company entered into a global collaboration and exclusive license agreement ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

Agreement provides Takeda with exclusive access to ENHANZE® drug delivery technology for vedolizumab SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Halozyme Therapeutics ...

We’ve all been there. You start feeling off, so you decide to Google your symptoms. Suddenly, WebMD has you convinced that ...

It’s important to be able to advocate for yourself when you visit the doctor. If you truly believe that there’s something ...

Although constipation and diarrhea may seem like opposite problems, they both hinge on the same underlying issue: how much ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab ...

Fossilized footprints, preserved in gypsum mud that hardened over time, are estimated to be 23,000-21,000 years old. NPS / Alamy Ancient human footprints, preserved in a dry lakebed at White Sands ...

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Halozyme ...